rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SAVA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board

      AUSTIN, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA), a biotechnology company focused on developing therapi...

      Nov 11Business InsiderSAVA
      Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update

      – Patient screening in Phase 2a study of simufilam in TSC-related epilepsy expected to begin by Q1 2027, following recent lift of FDA clinical hol...

      Nov 5Business InsiderSAVA
      Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
      Oct 28Yahoo FinanceSAVA
      Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
      Oct 9Yahoo FinanceSAVA
      Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

      Patient screening for the Phase 2a study is expected to begin by the first quarter of 2027Filana has engaged a leading clinical research organization, has identified clinical trial sites, and is recruiting potential investigatorsOngoing collaboration with the TSC Alliance and the broader TSC community is intended to support patient engagement and study execution AUSTIN, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a bio

      Sep 22Yahoo FinanceSAVA
      Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

      AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on...

      Aug 24BarchartPALDPALUSAVA

      This is the newest page. Registered accounts read further back.